|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Survival and Recurrence in Patients With Splanchnic Vein Thromboses显示文摘 | Mallikarjun R. Thatipelli Robert D. McBane David O. Hodge Waldemar E. Wysokinski | 2010 | Clinical Gastroenterology and Hepatology2010，，2： | 2 |
| 2 | Periprocedural Bridging Management of Anticoagulation显示文摘 | Wysokinski WE McBane II RD | | 0，，： | 1 |
| 3 | Thrombophilla differences in splanehnic vein thrombosis and lower extremity deep venous thrombosis in North America 显示文摘 | Sutkowska E McBane RD Tafur A J | 2013 | Gastroen- terol2013，48，10： | 1 |
| 4 | Formation e- valuation of exploration coalbed-methane wells显示文摘 | MAVOR M CLOSE J C MCBANE R A | 1994 | SPE Formation Evaluation1994，9，4： | 1 |
| 5 | Comparison ofplasminogen activator inhibitor -1, tissue type plasminogenactivator antigen, fibrinogen, and D-dimer levels in variousage decades in patients with type 2 diabetes mellitus and stablecoronary artery disease (from the BARI 2D trial) 显示文摘 | Mcbane RN Hardison RM Sobel BE | 2010 | Am JCardiol’2010，105，1： | 1 |
| 6 | Brain lesions in cerebral venous sinus thrombosis显示文摘 | Zubkov AY McBane RD Brown RD | | 0，，04： | 1 |
| 7 | Efficacy and safety of in-travenous phytonadione(Vitamin K1) in patients on longterm oral an-ticoagulant therapy显示文摘 | Shields RC McBane RD Kuiper JD | 2001 | Mayo Clin Proc2001，76，12： | 1 |
| 8 | Acquired and congenital risk factors associated with cerebral venous sinus thrombosis显示文摘 | McBane RD 2nd Tafur A Wysokinski WE | | 0，，02： | 1 |
| 9 | Biodegradation and in vivo biocompatihility of a degradable, polar/hydrophobic/ionic polyurethane for tissue engineering applications 显示文摘 | Mcbane J E Sharifpoor S Cai K | 2011 | Biomateri- als2011，32，26： | 1 |
| 10 | Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis显示文摘 | E M. Wysokinska W E. Wysokinski R D. Brown K Karnicki I Gosk-Beirska D Grill R D. McBane | 2008 | Neurology2008，，8： | 1 |
| 11 | Comparison of plasminogen activator inhibitor-1,tissue type plasminogen activator antigen,fibrinogen,and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease显示文摘 | McBane RD 2nd Hardison RM Sobel BE BARI 2D Study Group | 2010 | Am J Cardiol2010，105，1： | 1 |
| 12 | Biodegradation and in vivo biocompatibility of a degradable, polar/hydrophobic/ionic polyurethane for tissue engineering applications显示文摘 | Joanne E. McBane Soroor Sharifpoor Kuihua Cai Rosalind S. Labow J. Paul Santerre | 2011 | Biomaterials2011，，26： | 1 |
| 13 | Succinct review of the new VTE prevention and management guidelines 显示文摘 | Pollak AW McBane RD 2nd | 2014 | Mayo Clin Proc2014，89，3： | 1 |
| 14 | ACCP White Paper Te- nets for Developing Quality Measures for Ambulatory Clinical Pharmacy Services American College of Clinical Pharmacy显示文摘 | McBane S Trewet CB Havican SN | 2011 | Pharmacotherapy2011，31，7： | 1 |
| 15 | Brain lesions in cerebral venous sinus thrombosis显示文摘 | Zubkov A McBane RD Brown RD | 2009 | Stroke2009，40，： | 1 |
| 16 | Periprocedural an?ticoagulation management of patients with nonvalvular atrial fi bril?lation显示文摘 | Wysokinski WE McBane RD Daniels PR | 2008 | Mayo Clin Proc2008，83，6： | 1 |
| 17 | Peri-procedural anticoagu?lation management of mechanical prosthetic heart valve patients显示文摘 | Daniels PR McBane RD Litin SC | 2009 | Thromb Res2009，124，3： | 1 |
| 18 | Comparison of plasminogen activator inhibitor-l,tissue type plasminogen activator antigen,fibrinogen,and D-dimmer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial)显示文摘 | McBane RD 2nd Hardison RM Sobel BE | 2010 | Am J Cardio 12010，105，1： | 1 |
| 19 | Com- parison of plasminogen aetivator inhibitor-l, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 dia- betes mellitus and stable coronary artery disease (from the BARI 2D trial)显示文摘 | McBane RD 2ndl Hardison RM Sobel BE | 2010 | Am J Cardiol2010，105，1： | 1 |
| 20 | Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation显示文摘 | McBane RD Hodge DO Wysokinski WE | 2008 | Thromb Haemost2008，99，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员